期刊文献+

心房颤动患者植入冠脉药物洗脱支架不同抗栓方案对比分析

原文传递
导出
摘要 目的 对比心房颤动患者冠脉植入药物洗脱支架后不同抗栓治疗方案的临床效果.方法 入选67例郑州大学附属郑州中心医院心内科住院的永久性心房颤动和新发持续性心房颤动患者,住院期间行冠状动脉造影并植入药物洗脱支架1枚以上,根据术后服用抗栓药物分为三组,比较三组发生支架内血栓、缺血性脑卒中、心肌梗死、死亡及出血等事件.结果 随访12个月,三联组次要出血1例,轻微出血6例;双联组缺血性脑卒中2例,支架内血栓1例,全因死亡1例,轻微出血1例;单一组支架内血栓1例,心肌梗死1例,靶血管再血管化1例,轻微出血2例.结论 CHA2DS2评分≥2分的中高危患者给予三联抗血小板治疗,CHA2DS2评分为1或0分的低危患者停用华法林,应用双联抗血小板治疗也是可行的,针对不同患者的血栓形成风险选择不同的抗栓治疗方案.
作者 陈晖
出处 《中国实用医刊》 2015年第4期82-83,共2页 Chinese Journal of Practical Medicine
  • 相关文献

参考文献5

  • 1Camm AJ, Kirchhof P, Kip GY,et al. Guidelines for the managementof atrial Fibrillation: The Task Force for the Management of Atrial Fi-brillation of the European Society of Cardiology( ESC) [ J]. EurlleartJ,2010,31(19) :2369-429.
  • 2Hart RG,Pearce LA, Aguilar MI. Meta-analysis:antithrombotic thera-py to prevent stroke in patients who have nonvalvular atrialfibrillation[ J]. Ann Intern Med,2007 ,146( 12) :857-67.
  • 3卢革新.高危心房颤动患者应用华法林的安全性及有效性[J].临床医学,2011,31(3):72-73. 被引量:1
  • 4Hohnloser SH, Pajitnev D, Pogue J,et al. Incidence of stroke in par-oxysmal versus sustained atrial fibrillation in patients taking oral anti-coagulation or combined antiplatelet therapy : an ACTIVE WSubstudy [J]. J Am Coll Cardiol ,2007 ,50(22) :2156.
  • 5马长生,高凌云.心房纤颤患者脑卒中的预防-抗凝与抗血小板治疗[J].心肺血管病杂志,2010,29(3):245-247. 被引量:19

二级参考文献25

  • 1韩雅玲,王祖禄.心房颤动患者血栓栓塞并发症的防治[J].中国实用内科杂志,2006,26(2):177-179. 被引量:34
  • 2Wolf PA,Abbott RD,Kannel WB.Atrial fibrillation as an independent risk factor for stroke:the Framingham Study.Stroke,1991,22:983-988.
  • 3Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation:a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of canliology committee for practice guidelines(Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation):developed in collaboration with the European heart Rhythm association and the heart Rhythm society.Circulation,2006,1 14:e257-354.
  • 4Petersen P,Boysen G,Godtfredsen J,et al.Placebocontrolled.randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation.The Copenhagen AFASAK study.Lancet,1989,1:175-179.
  • 5Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.The European atrial fibrillation trial study group.N Engl J Med,1995,333:5-10.
  • 6Van Walraven C,Hart RG,Singer DE,et al.Oral anticoagulants vs aspitin in nonvalvular atrial fibrillation:an individual patient meta-analysis.JAMA,2002,288:2441-2448.
  • 7Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation:stroke prevention in atrial fibrillation Ⅱ study.Lancet,1994,343:687-691.
  • 8Kamath S,Blann AD,Chin BS,et al.A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.J Am Coll Cardiol,2002,40:484-490.
  • 9Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation.Analysis of pooled data from five randomized controlled trials.Arch Intern Med.1994,154:1449-1457.
  • 10Schwarz UI,Ritchie MD,Bradford Y,et al.Genetic determinants of response to warfarin during initial anticoagulation.N Engl J Med,2008,358:999-1008.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部